✦ LIBER ✦

Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone

✍ Scribed by Mr T. Bates; D. L. Riley; J. Houghton; L. Fallowfield; M. Baum

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 438 KB
Volume: 78
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800780523

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Indications for primary tamoxifen therap

Indications for primary tamoxifen therapy in elderly women with breast cancer

✍ D. J. Gaskell; R. A. Hawkins; S. De Carteret; U. Chetty; K. Sangster; Professor 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

Treatment of metastatic breast cancer in

Treatment of metastatic breast cancer in estrogen receptor positive patients a randomized trial comparing tamoxifen alone versus tamoxifen plus CMF

✍ W. R. Bezwoda; D. Derman; N. G. De Moor; M. Lange; J. Levin 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB 👁 2 views

Late follow-up of a randomized trial of

Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer

✍ M. Fennessy; T. Bates; K. MacRae; D. Riley; J. Houghton; M. Baum 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Background Breast cancer has been considered a more indolent disease in the elderly, who are less tolerant of aggressive therapy. This trial tested the hypothesis that tamoxifen without surgery would provide adequate control of breast cancer for the remainder of life in elderly wome

A randomized trial of tamoxifen alone or

A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma

✍ James N. Ingle; Vera J. Suman; Carl G. Kardinal; James E. Krook; James A. Mailli 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 2 views

## BACKGROUND. Tamoxifen (TAM) is generally considered the hormonal agent of choice for postmenopausal women with hormone receptor positive breast carcinoma. The somatostatin analogues, including octreotide, have demonstrated inhibition of breast carcinoma cell lines and multiple endocrinologic act